Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.


Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
12 2021
Historique:
received: 30 03 2021
accepted: 30 09 2021
entrez: 29 10 2021
pubmed: 30 10 2021
medline: 16 2 2022
Statut: ppublish

Résumé

Opioid overdose is a leading cause of death in the United States. The only treatment available currently is the competitive antagonist, naloxone (Narcan

Identifiants

pubmed: 34713624
doi: 10.1002/prp2.887
pmc: PMC8554411
doi:

Substances chimiques

Cinnamates 0
Ligands 0
Morphine Derivatives 0
Narcotic Antagonists 0
Receptors, Opioid, mu 0
methocinnamox 0
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- 100929-53-1
Naloxone 36B82AMQ7N
Cyclic AMP E0399OZS9N

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00887

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA038645
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA048214
Pays : United States

Informations de copyright

© 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.

Références

JAMA Intern Med. 2019 Jun 1;179(6):805-811
pubmed: 31058922
J Pharmacol Exp Ther. 2017 Jul;362(1):200-209
pubmed: 28465374
J Pharmacol Exp Ther. 2015 Apr;353(1):44-51
pubmed: 25637601
J Pharmacol Exp Ther. 2019 Nov;371(2):507-516
pubmed: 31439807
Mol Pharmacol. 2012 Jan;81(1):41-52
pubmed: 21989256
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297
pubmed: 32191688
Neuropsychopharmacology. 2020 Nov;45(12):1986-1993
pubmed: 32375158
J Pharmacol Exp Ther. 1986 Nov;239(2):351-7
pubmed: 3021954
MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5
pubmed: 26086633
Br J Pharmacol. 2021 May 24;:
pubmed: 34030211
BMJ. 2013 Jan 30;346:f174
pubmed: 23372174
J Med Chem. 2006 Oct 5;49(20):6104-10
pubmed: 17004724
J Pharmacol Exp Ther. 1996 Oct;279(1):23-31
pubmed: 8858971
Drug Alcohol Depend. 2020 Apr 1;209:107890
pubmed: 32058246
J Mol Model. 2019 May 3;25(5):144
pubmed: 31053968
Mol Pharmacol. 1987 Sep;32(3):321-9
pubmed: 2823089
J Med Chem. 2000 Feb 10;43(3):381-91
pubmed: 10669565
MMWR Morb Mortal Wkly Rep. 2019 May 03;68(17):388-395
pubmed: 31048676
Mol Pharmacol. 2012 Feb;81(2):264-72
pubmed: 22072818
J Pharmacol Exp Ther. 2011 Jul;338(1):92-9
pubmed: 21487072
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Ther Adv Drug Saf. 2018 Jan;9(1):63-88
pubmed: 29318006
Pain. 1988 Jan;32(1):77-88
pubmed: 3340425
Anesthesiology. 2010 Jan;112(1):226-38
pubmed: 20010421
Br J Pharmacol. 2021 Oct;178 Suppl 1:S27-S156
pubmed: 34529832
Drug Alcohol Depend. 2021 Jan 1;218:108384
pubmed: 33158665
Mol Pharmacol. 2018 Apr;93(4):376-386
pubmed: 29436492
J Pharmacol Exp Ther. 2007 Jun;321(3):839-47
pubmed: 17347322
JAMA Psychiatry. 2019 Feb 1;76(2):208-216
pubmed: 30516809
J Pharmacol Exp Ther. 2016 Dec;359(3):411-419
pubmed: 27660244
Curr Opin Pharmacol. 2009 Feb;9(1):3-8
pubmed: 19157985
Curr Protoc Pharmacol. 2008 Jun;Chapter 1:Unit1.2
pubmed: 22294216
Pharmacol Rev. 2010 Dec;62(4):701-25
pubmed: 21079041
Eur J Pharmacol. 2009 Jan 14;602(2-3):283-7
pubmed: 19063879
J Pharmacol Exp Ther. 2000 Sep;294(3):933-40
pubmed: 10945843
Nucleic Acids Res. 2020 Jan 8;48(D1):D1006-D1021
pubmed: 31691834
J Med Chem. 1980 Mar;23(3):233-4
pubmed: 6245210
J Pharmacol Exp Ther. 2019 Jan;368(1):88-99
pubmed: 30401680
Pharmacol Rev. 2002 Jun;54(2):323-74
pubmed: 12037145
Addiction. 2020 May;115(5):946-958
pubmed: 31912625

Auteurs

Joshua C Zamora (JC)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.

Hudson R Smith (HR)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.

Elaine M Jennings (EM)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.

Teresa S Chavera (TS)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.

Varun Kotipalli (V)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.

Aleasha Jay (A)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.

Stephen M Husbands (SM)

Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.

Alex Disney (A)

Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.

Kelly A Berg (KA)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Addiction Research, Treatment & Training Center of Excellence, UT Health San Antonio, San Antonio, Texas, USA.

William P Clarke (WP)

Department of Pharmacology, UT Health San Antonio, San Antonio, Texas, USA.
Addiction Research, Treatment & Training Center of Excellence, UT Health San Antonio, San Antonio, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH